MedAvail Holdings, Inc. MDVLQ

0.00 0.00 NaN as of 24 Sep
Market cap
$2.9M
P/E
0.0×
Jun '23 Mar '23 Dec '22 Sep '22 Older periods
ROE
(164.77%) (962.98%) (238.69%) (157.29%)

+8 more TTM periods

ROA
(111.18%) (163.78%) (133.61%) (96.46%)
ROIC
(291.50%) 0.00% (204.18%) (154.51%)
Return on Tangible Assets
(194.70%) (184.22%) (204.81%) (127.02%)
Average Days of Receivables
2.46 1.74 3.42 42.23
Free Cash Flow per Share
(17.93) (25.23) (37.98) (34.10)
Free Cash Flow
(32.23) (40.50) (49.97) (54.58)
Capital Expenditures
(0.69) (0.89) (2.30) (2.96)
Piotroski F-Score
5.00 5.00 4.00 3.00
Other line items
Cash ROIC
(79.26%) (156.48%) (123.96%) (74.12%)
Accounts Receivable Turnover
36.59 44.46 54.12 11.72
Accounts Payable Turnover
22.16 8.65 24.60 4.03
Inventory Turnover
5.18 5.91 6.37 3.43
Average Days of Payables
7.15 8.04 7.37 40.06
Days of Inventory on Hand
90.38 77.92 79.41 127.82
Tax Rate
0.00 0.00 0.00 0.00
Research and Development Expense of Revenue
2.21% 2.38% 2.59% 4.62%
Selling, General and Administrative Expense of Revenue
71.93% 73.13% 74.20% 134.55%
Share Based Compensation of Revenue
4.89% 5.41% 5.33% 10.22%
Interest Coverage
0.00 0.00 0.00 0.00
Operating CF/Net income
0.69 0.76 1.00 1.05
Depreciation/Fixed assets
6.81 6.59 11.22 0.66
Capex/Depreciation
(0.14) (0.17) (0.47) (0.71)
Revenue per Share
24.10 27.07 32.77 12.21
Operating CF per Share
(17.54) (24.67) (36.23) (32.25)
Capex per Share
(0.39) (0.55) (1.75) (1.85)
Capex to Sales
0.02 0.02 0.05 0.15
Net Profit Margin
(106.16%) (119.46%) (110.45%) (251.53%)

Fold the line items

Columns are period end dates